Close Menu

NEW YORK (GenomeWeb) —Institute for Systems Biology spinout Arivale plans to provide customers with personalized health recommendations based on a variety of molecular and lifestyle datasets, including their genome sequence.

The company, co-founded in early 2014 by ISB President Lee Hood, CEO Clayton Lewis, and ISB Associate Director Nathan Price, said today that it raised $36 million in a Series B funding round that was led by venture firms Arch Venture Partners and Polaris Partners. Maveron, which led Arivale's $3 million Series A round, also participated in the latest round.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.